3 transcripts
NTRA
Earnings call transcript
NASDAQ
2024 Q1
9 May 24
a 53 fold increased risk of death compared to those who test a persistently negative on Signatera. The diagnostic lead times were also longer than
NTRA
Earnings call transcript
NASDAQ
2023 Q4
28 Feb 24
in the United States has a median age of diagnosis of 63 years and is the fifth leading cause of cancer death in women. Current tools, including imaging
NTRA
Earnings call transcript
NASDAQ
2023 Q2
3 Aug 23
of death and patients who achieved ctDNA clearance or a deep reduction of at least 90% had significantly improved outcomes.
This study was well received
- Prev
- 1
- Next